Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 366
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Sodium Salicyl 80 % WSP 800 mg/g V/MRP/11/0057 Dopharma Research B.V., Nīderlande QN02BA04 cattle (calf); pigs Vairāk

Medicinal product information

Pharmaceutical form: powder for oral solution
International name (active substance): Sodium salicylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 02-Oct-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 300322LI (30-Mar-2022)
Labelling text: [DOCX] 300322M (30-Mar-2022)
Summary of product characteristics: [DOCX] 300322ZA (30-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0057-01 800 mg/g 1 Polietilēna spainis, 1 kg -
V/MRP/11/0057-02 800 mg/g 1 Polietilēna spainis, 2,5 kg -
V/MRP/11/0057-03 800 mg/g 1 Polietilēna spainis, 5 kg -
V/MRP/11/0057-04 800 mg 1 Polipropilēna konteiners, 1 kg -
V/MRP/11/0057-05 800 mg/g 1 Kanna, 1 kg -
BioEquin H - V/MRP/15/0056 Bioveta, a.s., Čehija QI05AA05 horses Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated equine herpes virus type 1
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 30-Jan-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 160523LI (16-May-2023)
Labelling text: [PDF] 310119M (31-Jan-2019)
Summary of product characteristics: [DOCX] 160523ZA (16-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0056-01 2 Stikla flakons, 1 deva -
V/MRP/15/0056-02 5 Stikla flakons, 1 deva -
V/MRP/15/0056-03 10 Stikla flakons, 1 deva -
V/MRP/15/0056-04 1 Stikla flakons, 5 deva -
V/MRP/15/0056-05 10 Stikla flakons, 5 deva -
HIPRAGUMBORO GM97 - V/MRP/18/0034 Laboratorios Hipra S.A., Spānija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oral suspension
International name (active substance): Live Infectious bursitis virus, strain GM97
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 02-Jan-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0034-01 1 Stikla flakons, 1000 deva -
V/MRP/18/0034-02 1 Stikla flakons, 5000 deva -
V/MRP/18/0034-03 10 Stikla flakons, 1000 deva -
V/MRP/18/0034-04 10 Stikla flakons, 5000 deva -
Caninsulin vet. 40 IU/ml V/MRP/13/0021 Intervet International B.V., Nīderlande QA10AC03 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Porcine insulin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International GmbH, Vācija
Date of authorisation/renewal: 27-Oct-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Sep-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0021-01 40 IU/ml 10 Stikla flakons, 2,5 ml -
V/MRP/13/0021-02 40 IU/ml 10 Stikla flakons, 10 ml -
V/MRP/13/0021-03 40 IU/ml 10 Stikla kārtridžs, 2,7 ml -
Censulfatrim 200 mg/ml + 40 mg/ml - V/MRP/23/0008 Cenavisa S.L, Spānija QJ01EW10 cattle; pigs; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Sulfadiazine, Trimethoprim
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 28-Mar-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/23/0008-01 1 Stikla flakons, 100 ml -
V/MRP/23/0008-02 1 Stikla flakons, 250 ml -
V/MRP/23/0008-03 10 Stikla flakons, 100 ml -
V/MRP/23/0008-04 10 Stikla flakons, 250 ml -
MULTIMIN - V/MRP/21/0020 Warburton Technology Limited, Īrija QA12CX99 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Zinc oxide, Manganese carbonate, Sodium selenite, COPPER(II) CARBONATE
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratoires Biove, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0020-01 1 PET flakons, 100 ml -
V/MRP/21/0020-02 1 PET flakons, 500 ml -
Cepetor 1 mg/ml V/MRP/07/1685 CP-Pharma Handelsgesellschaft GmbH, Vācija QN05CM91 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Medetomidine hydrohloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP Pharma GmbH, Vācija
Date of authorisation/renewal: 16-Dec-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (07-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1685-01 1 mg/ml 1 Stikla pudelīte, 10 ml -
V/MRP/07/1685-02 1 mg/ml 5 Stikla pudelīte, 10 ml -
Prednisolonacetat-Injektionssuspension 10 mg/ml V/NRP/95/0123 AS Dimedium Latvija, Latvija QH02AB06 cattle; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Prednisolone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 21-May-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 18122020LI (18-Dec-2020)
Labelling text: [DOCX] 18122020M (18-Dec-2020)
Summary of product characteristics: [DOCX] 18122020ZA (18-Dec-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0123-01 10 mg/ml 1 Flakons, 100 ml -
V/NRP/95/0123-02 10 mg/ml 12 Flakons, 100 ml -
Nobilis Gumboro 228E - V/NRP/95/0176 Intervet International B.V., Nīderlande QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Infectious bursal disease virus, strain LZD 228E, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0176-01 10 Stikla flakons, 1000 deva -
V/NRP/95/0176-02 10 Stikla flakons, 2500 deva -
V/NRP/95/0176-03 10 Stikla flakons, 5000 deva -
V/NRP/95/0176-04 12 Kausiņš, 1000 deva -
V/NRP/95/0176-05 12 Kausiņš, 2500 deva -
V/NRP/95/0176-06 12 Kausiņš, 5000 deva -
V/NRP/95/0176-07 12 Kausiņš, 10000 deva -
V/NRP/95/0176-08 6 Kausiņš, 10000 deva -
Spizobactin vet 750000 IU/125 mg - V/DCP/17/0037 Le Vet Beheer B.V., Nīderlande QJ01RA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Spiramycin, Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 27-Sep-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0037-01 1 Blisteris, 10 tablete -
V/DCP/17/0037-02 2 Blisteris, 10 tablete -
V/DCP/17/0037-03 3 Blisteris, 10 tablete -
V/DCP/17/0037-04 10 Kastīte ar blisteri, 10 tablete -
V/DCP/17/0037-05 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
Spizobactin vet 1500000 IU/250 mg - V/DCP/17/0038 Le Vet Beheer B.V., Nīderlande QJ01RA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Spiramycin, Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 27-Sep-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0038-01 1 Blisteris, 10 tablete -
V/DCP/17/0038-02 2 Blisteris, 10 tablete -
V/DCP/17/0038-03 3 Blisteris, 10 tablete -
V/DCP/17/0038-04 10 Kastīte ar blisteri, 10 tablete -
V/DCP/17/0038-05 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
Spizobactin vet 3000000 IU/500 mg - V/DCP/17/0039 Le Vet Beheer B.V., Nīderlande QJ01RA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Spiramycin, Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 27-Sep-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0039-01 1 Blisteris, 10 tablete -
V/DCP/17/0039-02 2 Blisteris, 10 tablete -
V/DCP/17/0039-03 3 Blisteris, 10 tablete -
V/DCP/17/0039-04 10 Kastīte ar blisteri, 10 tablete -
V/DCP/17/0039-05 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
Clindabactin 55 mg V/DCP/19/0025 Dechra Regulatory B.V., Nīderlande QJ01FF01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Clindamycin (as Clindamycin hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0025-01 55 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-02 55 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-03 55 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-04 55 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-05 55 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-06 55 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-07 55 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-08 55 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-09 55 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-10 55 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-11 55 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-12 55 mg 10 Kastīte ar Al/OPA/Al/PVH blisteri, 10 tablete -
Clindabactin 220 mg V/DCP/19/0026 Dechra Regulatory B.V., Nīderlande QJ01FF01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Clindamycin (as Clindamycin hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0026-01 220 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-02 220 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-03 220 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-04 220 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-05 220 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-06 220 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-07 220 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-08 220 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-09 220 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-10 220 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-11 220 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-12 220 mg 10 Kastīte ar Al/OPA/Al/PVH blisteri, 10 tablete -
Clindabactin 440 mg V/DCP/19/0027 Dechra Regulatory B.V., Nīderlande QJ01FF01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Clindamycin (as Clindamycin hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0027-01 440 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-02 440 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-03 440 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-04 440 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-05 440 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-06 440 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-07 440 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-08 440 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-09 440 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-10 440 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-11 440 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-12 440 mg 10 Kastīte ar Al/OPA/Al/PVH blisteri, 10 tablete -
Alfaxan Multidose 10 mg/ml V/MRP/21/0071 Zoetis Belgium S.A., Beļģija QN01AX05 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Alfaxalone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0071-01 1 Stikla flakons, 10 ml -
V/MRP/21/0071-02 1 Stikla flakons, 20 ml -
Milpro 12,5 mg/125 mg - V/MRP/20/0028 VIRBAC, Francija QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/20/0028-01 12,5 mg/125 mg 1 Al/Al blisteris, 2 tablete -
V/MRP/20/0028-02 12,5 mg/125 mg 2 Al/Al blisteris, 2 tablete -
V/MRP/20/0028-03 12,5 mg/125 mg 12 Al/Al blisteris, 2 tablete -
V/MRP/20/0028-04 12,5 mg/125 mg 24 Al/Al blisteris, 2 tablete -
Vetbromide 600 mg V/DCP/21/0011 DOMES PHARMA, Francija QN03AX91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets for oral use
International name (active substance): Potassium bromide
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Europhartech, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0011-01 600 mg 4 Blisteris, 15 tablete -
V/DCP/21/0011-02 600 mg 8 Blisteris, 15 tablete -
EVOCTIN PLUS 10 mg/ml + 100 mg/ml - V/DCP/25/0021 Adoh B.V., Nīderlande QP54AA51 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin, Clorsulon
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pasteur Filiala Pilipesti S.A., Rumānija
Date of authorisation/renewal: 01-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0021-01 1 Stikla pudele (brūna), 100 ml -
V/DCP/25/0021-02 1 Stikla pudele (brūna), 250 ml -
V/DCP/25/0021-03 1 Stikla pudele (brūna), 500 ml -
Marbofloxacin Bioveta 100 mg/ml V/DCP/25/0022 Bioveta, a.s., Čehija QJ01MA93 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 01-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0022-01 1 Stikla flakons, 100 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy